Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | RET |
Variant | Y806C |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | RET Y806C lies within the protein kinase domain of the Ret protein (UniProt.org). Y806C is predicted to lead to a gain of Ret protein function as indicated by transformation of cultured cells (PMID: 10679286), and has also been demonstrated to occur as a secondary resistance mutation in conjunction with other RET mutations (PMID: 19029224). |
Associated Drug Resistance | Y |
Category Variants Paths |
RET mutant RET act mut RET Y806C |
Transcript | NM_020975.6 |
gDNA | chr10:g.43119555A>G |
cDNA | c.2417A>G |
Protein | p.Y806C |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_020630 | chr10:g.43119555A>G | c.2417A>G | p.Y806C | RefSeq | GRCh38/hg38 |
NM_001406771.1 | chr10:g.43123724A>G | c.2417A>G | p.Y806C | RefSeq | GRCh38/hg38 |
NM_020975 | chr10:g.43119555A>G | c.2417A>G | p.Y806C | RefSeq | GRCh38/hg38 |
NM_001406759.1 | chr10:g.43119555A>G | c.2417A>G | p.Y806C | RefSeq | GRCh38/hg38 |
NM_020630.7 | chr10:g.43119555A>G | c.2417A>G | p.Y806C | RefSeq | GRCh38/hg38 |
NM_001406773.1 | chr10:g.43123724A>G | c.2417A>G | p.Y806C | RefSeq | GRCh38/hg38 |
NM_001406744.1 | chr10:g.43119555A>G | c.2417A>G | p.Y806C | RefSeq | GRCh38/hg38 |
NM_001406760.1 | chr10:g.43119555A>G | c.2417A>G | p.Y806C | RefSeq | GRCh38/hg38 |
NM_020630.5 | chr10:g.43119555A>G | c.2417A>G | p.Y806C | RefSeq | GRCh38/hg38 |
NM_020975.6 | chr10:g.43119555A>G | c.2417A>G | p.Y806C | RefSeq | GRCh38/hg38 |
NM_001406774.1 | chr10:g.43124885A>G | c.2417A>G | p.Y806C | RefSeq | GRCh38/hg38 |
NM_001406743.1 | chr10:g.43119555A>G | c.2417A>G | p.Y806C | RefSeq | GRCh38/hg38 |
NM_020975.5 | chr10:g.43119555A>G | c.2417A>G | p.Y806C | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
RET Y806C | Advanced Solid Tumor | sensitive | Ponatinib | Preclinical | Actionable | In a preclinical study, Iclusig (ponatinib) inhibited phosphorylation of Ret in transformed human cells expressing RET Y806C in culture (PMID: 23526464). | 23526464 |